Beyond First Line CDK4/6 Inhibitors (CDK4/6i) and Aromatase Inhibitors (AI) in Patients with Oestrogen Receptor Positive Metastatic Breast Cancer (ER+ MBC): The Guy’s Cancer Centre Experience

Autor:	C. Gousis, K. Michoglou, H. Lowe, M. Kapiris, V. Angelis
Rok vydání:	2022
Předmět:	Oncology Radiology Nuclear Medicine and imaging
Zdroj:	Clinical Oncology. 34:e178
ISSN:	0936-6555
DOI:	10.1016/j.clon.2021.12.030
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e98b7676ac30968d8a83b7f5be957cb0 https://doi.org/10.1016/j.clon.2021.12.030 Zobrazit plný text záznamu Full Text from ScienceDirect